(Q44113798)

29 November 2017

title

Plasma hydrazine concentrations in man after isoniazid and hydralazine administration (English)

1 reference

29 November 2017

1 reference

0 references

Blair IA

1

1 reference

29 November 2017

Mansilla Tinoco R

2

1 reference

29 November 2017

Brodie MJ

3

1 reference

29 November 2017

Clare RA

4

1 reference

29 November 2017

Dollery CT

5

1 reference

29 November 2017

Timbrell JA

6

1 reference

29 November 2017

Beever IA

7

1 reference

29 November 2017

publication date

1 March 1985

1 reference

29 November 2017

1 reference

29 November 2017

volume

4

1 reference

29 November 2017

issue

2

1 reference

29 November 2017

page(s)

195-202

1 reference

Drug-induced antinuclear antibodies and lupus syndromes

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F096032718500400210

Isoniazid acetylatlon rate and development of antinuclear antibodies upon isoniazid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096032718500400210

The role of vitamin B6 in the toxicity of hydrazines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096032718500400210

Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096032718500400210

Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096032718500400210

Incidence of hepatotoxic side effects during antituberculous therapy (INH, RMP, EMB) in relation to the acetylator phenotype (author's transl)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096032718500400210

An improved and simplified method of detecting the acetylator phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096032718500400210

Studies on hydrazine hepatotoxicity. 1. Pathological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096032718500400210

Identification and quantitation of hydrazine in the urine of patients treated with hydralazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096032718500400210

Carcinogenicity of Hydrazine and 1,1-Dimethylhydrazine for Mouse Lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096032718500400210

10.1177/096032718500400210

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference